Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Price:
3.15
USD
2.27%
Market Closed
Market Cap:
$809.8m
Balance Sheet
Balance Sheet Decomposition
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc
Balance Sheet Decomposition is not available for
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc
Balance Sheet
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
22
|
25
|
236
|
551
|
632
|
575
|
322
|
217
|
|
| Cash |
22
|
25
|
236
|
551
|
632
|
575
|
322
|
217
|
|
| Total Receivables |
16
|
19
|
51
|
118
|
147
|
56
|
39
|
25
|
|
| Accounts Receivables |
16
|
19
|
51
|
118
|
139
|
55
|
39
|
25
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
8
|
1
|
0
|
0
|
|
| Inventory |
14
|
14
|
33
|
52
|
43
|
51
|
50
|
40
|
|
| Other Current Assets |
2
|
3
|
11
|
20
|
26
|
18
|
18
|
13
|
|
| Total Current Assets |
54
|
61
|
332
|
740
|
848
|
700
|
429
|
296
|
|
| PP&E Net |
43
|
94
|
101
|
95
|
117
|
223
|
217
|
191
|
|
| PP&E Gross |
43
|
94
|
101
|
95
|
117
|
223
|
217
|
191
|
|
| Accumulated Depreciation |
4
|
8
|
11
|
13
|
20
|
32
|
53
|
68
|
|
| Intangible Assets |
218
|
198
|
178
|
118
|
217
|
221
|
195
|
152
|
|
| Goodwill |
224
|
224
|
224
|
153
|
284
|
326
|
160
|
129
|
|
| Other Long-Term Assets |
1
|
1
|
436
|
813
|
818
|
18
|
7
|
3
|
|
| Other Assets |
224
|
224
|
224
|
153
|
284
|
326
|
160
|
129
|
|
| Total Assets |
540
N/A
|
578
+7%
|
1 271
+120%
|
1 918
+51%
|
2 282
+19%
|
1 487
-35%
|
1 008
-32%
|
771
-24%
|
|
| Liabilities | |||||||||
| Accounts Payable |
4
|
8
|
8
|
8
|
6
|
11
|
12
|
3
|
|
| Accrued Liabilities |
11
|
17
|
29
|
29
|
51
|
57
|
33
|
30
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
3
|
6
|
6
|
5
|
6
|
6
|
6
|
|
| Other Current Liabilities |
19
|
3
|
88
|
50
|
48
|
14
|
6
|
6
|
|
| Total Current Liabilities |
36
|
30
|
131
|
94
|
110
|
87
|
57
|
45
|
|
| Long-Term Debt |
337
|
388
|
585
|
525
|
522
|
551
|
322
|
316
|
|
| Deferred Income Tax |
16
|
15
|
9
|
0
|
0
|
0
|
0
|
2
|
|
| Minority Interest |
4
|
3
|
66
|
230
|
360
|
373
|
252
|
160
|
|
| Other Liabilities |
3
|
1
|
392
|
755
|
745
|
59
|
52
|
34
|
|
| Total Liabilities |
395
N/A
|
436
+10%
|
1 182
+171%
|
1 603
+36%
|
1 737
+8%
|
1 071
-38%
|
683
-36%
|
558
-18%
|
|
| Equity | |||||||||
| Common Stock |
183
|
184
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Retained Earnings |
38
|
42
|
1
|
185
|
405
|
286
|
141
|
10
|
|
| Additional Paid In Capital |
0
|
0
|
85
|
128
|
138
|
129
|
182
|
199
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
144
N/A
|
141
-2%
|
89
-37%
|
316
+256%
|
545
+73%
|
417
-24%
|
325
-22%
|
212
-35%
|
|
| Total Liabilities & Equity |
540
N/A
|
578
+7%
|
1 271
+120%
|
1 918
+51%
|
2 282
+19%
|
1 487
-35%
|
1 008
-32%
|
771
-24%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
258
|
258
|
258
|
255
|
255
|
251
|
253
|
256
|
|
Switch to:
Switch to:
See Also
Discover More
